Papers

2

Total Citations

20

H-Index

2

About

Dr. Hai Bi is a pioneering urologic surgeon whose research focuses on advancing minimally invasive techniques for complex renal cancers, particularly those involving venous tumor thrombus. His major contributions center on refining robot-assisted laparoscopic inferior vena cava thrombectomy (RAL-IVCT), a high-risk procedure for renal cell carcinoma extending into the venous system. In a landmark 2022 propensity-matched cohort study (14 citations), Dr. Bi demonstrated that robotic and laparoscopic approaches achieve comparable surgical and oncologic outcomes to open surgery for radical nephrectomy with venous thrombectomy, while offering reduced morbidity. Building on this, his 2023 prospective cohort study (6 citations) introduced a novel cephalic IVC non-clamping technique for level II–III thrombi, challenging the standard clamping approach to potentially reduce hemodynamic instability and operative complexity. This work addresses the critical 4-10% of renal tumor patients with venous invasion, expanding the applicability of robotic surgery. Dr. Bi’s research is instrumental in establishing evidence-based protocols that make complex thrombectomy safer and more accessible, positioning him as a key innovator in urologic oncology and robotic surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
20
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Comparative analysis of surgical and oncologic outcomes of robotic, laparoscopic and open radical nephrectomy with venous thrombectomy: a propensity-matched cohort study
14 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Peking University, Artistic Realization Technologies

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago